Literature DB >> 27512489

Unplanned pregnancy on a direct oral anticoagulant (Rivaroxaban): A warning.

B Myers1, R Neal2, O Myers3, M Ruparelia3.   

Abstract

Direct oral anticoagulants (DOACs or NOACs -non-vitamin K oral anticoagulants), as the name suggests, are oral anticoagulants with a direct inhibitory action either against factor X or factor II (thrombin). Pregnant women were excluded from participating in all the large trials of the DOACs and they are considered contra-indicated in pregnancy and breast feeding. We present a case of inadvertent exposure to rivaroxaban in a woman who presented at 25 weeks' gestation. The management of her pregnancy and delivery is described, and the previous published case reports are reviewed with a discussion about the use of DOACs in woman of childbearing age.

Entities:  

Keywords:  Anticoagulants; Rivaroxaban; direct oral anticoagulants; heavy menstrual bleeding; pregnancy

Year:  2015        PMID: 27512489      PMCID: PMC4950440          DOI: 10.1177/1753495X15621814

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  5 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists.

Authors:  Nico De Crem; Kathelijne Peerlinck; Thomas Vanassche; Kristine Vanheule; Barbara Debaveye; Saskia Middeldorp; Peter Verhamme; Marijke Peetermans
Journal:  Thromb Res       Date:  2015-08-04       Impact factor: 3.944

3.  Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation.

Authors:  Farah Yasmine Huq; Katerina Tvarkova; Aliaa Arafa; Rezan A Kadir
Journal:  Contraception       Date:  2011-02-11       Impact factor: 3.375

4.  Oral anticoagulation with rivaroxaban during pregnancy: a case report.

Authors:  O Königsbrügge; M Langer; M Hayde; C Ay; I Pabinger
Journal:  Thromb Haemost       Date:  2014-07-24       Impact factor: 5.249

Review 5.  Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review.

Authors:  Kelly R Culwell; Kathryn M Curtis
Journal:  Contraception       Date:  2009-06-10       Impact factor: 3.375

  5 in total
  3 in total

Review 1.  Pregnancy and Pulmonary Embolism.

Authors:  Christopher Deeb Dado; Andrew Tobias Levinson; Ghada Bourjeily
Journal:  Clin Chest Med       Date:  2018-09       Impact factor: 2.878

2.  Reproductive issues in women on direct oral anticoagulants.

Authors:  Jan Beyer-Westendorf; Sandra Marten
Journal:  Res Pract Thromb Haemost       Date:  2021-05-03

3.  Preeclampsia-Associated Multivessel Spontaneous Coronary Artery Dissection.

Authors:  Rajeev Virender Seecheran; Jessica Kawall; Divya Ramadhin; Valmiki Krishna Seecheran; Sangeeta Anjali Persad; Sasha Savitri Lalla; Naveen Anand Seecheran
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.